Screener
Rocket Pharmaceuticals RCKT Q4 2025 Annual earnings
Reported February 26, 2026 · Before market open
EPS-$0.38Beat by $0.04
Revenue estimate$277.8K
EPS estimate-$0.42
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$200.0K
EPS estimate-$0.39
Versus estimates
Diluted EPS
FAQ
- When did Rocket Pharmaceuticals report Q4 2025 earnings?
- Rocket Pharmaceuticals (RCKT) reported Q4 2025 earnings on February 26, 2026 before market open.
- What were Rocket Pharmaceuticals's Q4 2025 revenue and EPS?
- Rocket Pharmaceuticals reported eps of $-0.38 for Q4 2025.
- Did Rocket Pharmaceuticals beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.42 by $0.04.
- How did Rocket Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 38.7% from $-0.62.
- Where can I find Rocket Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001140361-26-006981) and the 10-K periodic report (0001193125-26-076551) directly on SEC EDGAR. The filing index links above go to sec.gov.
